Zevra Therapeutics Inc (ZVRA)

R&D Expenses

$4.49M

Quarterly · Period ending: · USD

ZVRA logo

ZVRA R&D Expenses

Latest reported$4.49M
ZVRA Quarterly R&D Expenses ($793.90K → $4.49M)
High-resolution chart · PNG

ZVRA r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Zevra Therapeutics Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
4,486,000
4,392,000
2,620,000
3,432,000
3,433,000
3,258,000
9,914,000
10,945,000
10,521,000
10,715,000
10,445,000
12,297,000
7,433,000
8,655,000
-11,311,000
5,385,000
22,458,000
3,082,000
2,809,000
2,239,000
2,848,000
2,265,000
3,054,000
1,709,000
1,954,000
2,126,000
2,465,000
3,616,000
4,803,000
8,531,000
6,304,000
13,330,000
10,488,000
11,637,000
5,536,000
6,293,000
4,650,000
4,114,000
7,973,000
4,287,000
4,988,000
3,234,000
4,716,000
4,328,000
2,768,000
2,119,000
5,911,217
3,253,000
1,715,000
1,038,000
793,904
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.